Initial Boston Scientific vaginal mesh trials set to erupt in March

Boston Scientific ($BSX) goes to trial on March 10, 2014, to face the first four cases alleging that the company's transvaginal mesh implant devices harmed patients. The Worcester Business Journal reported recently that a West Virginia district judge set the date. Two of the trials involve the Massachusetts company's Pinnacle transvaginal mesh, while two others cover its Obtryx mesh device, according to the article. Reportedly, close to 6,400 lawsuits remain. Boston Scientific, C.R. Bard ($BCR), Endo Health Solutions ($ENDP), Coloplast in Denmark and Cook Medical are among makers of vaginal mesh that face thousands of lawsuits in the U.S. alone alleging that their implants harmed countless women. All are reportedly in discussions with plaintiffs focused on a settlement. Story

Suggested Articles

BD will begin working with Babson Diagnostics to help bring its lab-quality device for collecting blood from capillaries into retail pharmacies.

The former CEO of the molecular testing company Foundation Medicine, Troy Cox, has been named chairman of the Swiss big data firm Sophia Genetics.

Researchers at MIT used a machine-learning algorithm to uncover the potent antibiotic properties hiding within an old small-molecule candidate.